Screening for hemoglobinopathies in newborns: reaffirmation update for the U.S. Preventive Services Task Force
Lin K, Barton MB
Record ID 32008000058
English
Authors' objectives:
To assist the USPSTF in updating its 1996 recommendation on screening for hemoglobinopathies in newborns, staff at the Agency for Healthcare Research and Quality (AHRQ) performed a literature search and consulted with subject area experts.The goal of this targeted review was to find new, high-quality evidence regarding the benefits and potential harms of screening for hemoglobinopathies in newborns.
Authors' recommendations:
In summary, we found no substantial new evidence since 1996 on the benefits or harms of screening for hemoglobinopathies in newborns. Future research is needed to identify counseling practices that minimize negative psychosocial effects of communicating newborn carrier status information and to develop alternative screening methods that are capable of identifying only clinically significant hemoglobinopathies.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.ahrq.gov/clinic/serfiles.htm
Year Published:
2007
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Anemia, Sickle Cell
- Infant, Newborn
- Mass Screening
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name:
martin.erlichman@ahrq.hhs.gov
Contact Email:
martin.erlichman@ahrq.hhs.gov
Copyright:
Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.